Effects of natural products on Mcl-1 expression and function

Current Medicinal Chemistry

Volumn 22, Issue 30, 2015, Pages 3447-3461

  Muller, Florian ^a   Cerella, Claudia ^a   Radogna, Flavia ^a   Dicato, Mario ^a   Diederich, Marc ^b  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b Seoul National University   (South Korea)

Author keywords

Apoptosis; Cancer; Mcl 1; Natural compounds

Indexed keywords

NATURAL PRODUCT; PROTEIN BCL 2; PROTEIN MCL 1; BIOLOGICAL PRODUCT; CARDENOLIDE; UNBS 1450;

APOPTOSIS; ARTICLE; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TARGETING; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASMS;

BIOLOGICAL PRODUCTS; CARDENOLIDES; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR STRUCTURE; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84946593591     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150716115435     Document Type: Article

References (53)

1. Sawadogo, W. R.; Schumacher, M.; Teiten, M. H.; Dicato, M.; Diederich, M. Traditional West African pharmacopeia, plants and derived compounds for cancer therapy. Biochem. Pharmacol., 2012, 84(10), 1225-1240.
2. Juncker, T.; Cerella, C.; Teiten, M. H.; Morceau, F.; Schumacher, M.; Ghelfi, J.; Gaascht, F.; Schnekenburger, M.; Henry, E.; Dicato, M.; Diederich, M. UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells. Biochem. Pharmacol., 2011, 81(1), 13-23.
3. Gaascht, F.; Teiten, M. H.; Cerella, C.; Dicato, M.; Bagrel, D.; Diederich, M. Plumbagin modulates leukemia cell redox status. Molecules, 2014, 19(7), 10011-10032.
4. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: the next generation. Cell, 2011, 144(5), 646-674.
5. Chao, D. T.; Korsmeyer, S. J. BCL-2 family: regulators of cell death. Annu. Rev. Immunol., 1998, 16, 395-419.
6. Borner, C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol., 2003, 39(11), 615-647.
7. Muchmore, S. W.; Sattler, M.; Liang, H.; Meadows, R. P.; Harlan, J. E.; Yoon, H. S.; Nettesheim, D.; Chang, B. S.; Thompson, C. B.; Wong, S. L.; Ng, S. L.; Fesik, S. W. Xray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature, 1996, 381(6580), 335-341.
8. Hunter, J. J.; Parslow, T. G. A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J. Biol. Chem., 1996, 271(15), 8521-8524.
9. Youle, R. J.; Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol., 2008, 9(1), 47-59.
10. Dewson, G.; Kluck, R. M. Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J. Cell Sci., 2009, 122(Pt 16), 2801-2808.
11. Rahman, M. A.; Kim, N. H.; Yang, H.; Huh, S. O. Angelicin induces apoptosis through intrinsic caspasedependent pathway in human SH-SY5Y neuroblastoma cells. Mol. Cell Biochem., 2012, 369(1-2), 95-104.
12. Chen, W.; Liu, L.; Luo, Y.; Odaka, Y.; Awate, S.; Zhou, H.; Shen, T.; Zheng, S.; Lu, Y.; Huang, S. Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspaseindependent cell death in tumor cells. Cancer Preven. Res., 2012, 5(5), 778-787.
13. Liu, P.; Liang, H.; Xia, Q.; Li, P.; Kong, H.; Lei, P.; Wang, S.; Tu, Z. Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression. Clin. Transl. Oncol., 2013, 15(9), 741-746.
14. Chanvorachote, P.; Pongrakhananon, V. Ouabain downregulates Mcl-1 and sensitizes lung cancer cells to TRAIL-induced apoptosis. Am. J. Physiol. Cell Physiol., 2013, 304(3), C263-272.
15. Lee, D. H.; Lee, C. S.; Kim, D. W.; Ae, J. E.; Lee, T. H. Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin. Anticancer Drugs, 2014, 25(1), 44-52.
16. Yan, S.; Qu, X.; Xu, L.; Che, X.; Ma, Y.; Zhang, L.; Teng, Y.; Zou, H.; Liu, Y. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells. Anticancer Drugs, 2014, 25(6), 683-689.
17. Peng, C. Y.; Yang, H. W.; Chu, Y. H.; Chang, Y. C.; Hsieh, M. J.; Chou, M. Y.; Yeh, K. T.; Lin, Y. M.; Yang, S. F.; Lin, C. W. Caffeic Acid phenethyl ester inhibits oral cancer cell metastasis by regulating matrix metalloproteinase-2 and the mitogen-Activated protein kinase pathway. Evid. Based Complement Alternat Med., 2012, 2012, 732578.
18. Jacquemin, G.; Granci, V.; Gallouet, A. S.; Lalaoui, N.; Morle, A.; Iessi, E.; Morizot, A.; Garrido, C.; Guillaudeux, T.; Micheau, O. Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells. Haematologica, 2012, 97(1), 38-46.
19. Spagnuolo, C.; Cerella, C.; Russo, M.; Chateauvieux, S.; Diederich, M.; Russo, G. L. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. Br. J. Cancer, 2011, 105(2), 221-230.
20. Guzey, M.; Kitada, S.; Reed, J. C. Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer. Mol. Cancer Ther., 2002, 1(9), 667-677.
21. Kim, J. A.; Kim, Y.; Kwon, B. M.; Han, D. C. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70), and Bcl-2-Associated athanogene domain 3 (BAG3), expression by blocking heat shock factor 1 (HSF1), binding to promoters. J. Biol. Chem., 2013, 288(40), 28713-28726.
22. Cerella, C.; Radogna, F.; Dicato, M.; Diederich, M. Natural compounds as regulators of the cancer cell metabolism. Int. J. Cell Biol., 2013, 2013, 639401.
23. Beevers, C. S.; Chen, L.; Liu, L.; Luo, Y.; Webster, N. J.; Huang, S. Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res., 2009, 69(3), 1000-1008.
24. Cerella, C.; Teiten, M. H.; Radogna, F.; Dicato, M.; Diederich, M. From nature to bedside: Pro-survival and cell death mechanisms as therapeutic targets in cancer treatment. Biotechnol. Adv., 2014, 32(6), 1111-1122.
25. Zhang, S.; Yin, J.; Li, X.; Zhang, J.; Yue, R.; Diao, Y.; Li, H.; Wang, H.; Shan, L.; Zhang, W. Jacarelhyperol A induced apoptosis in leukaemia cancer cell through inhibition the activity of Bcl-2 proteins. BMC Cancer, 2014, 14, 689.
26. Harper, M. T.; Poole, A. W. Bcl-xL-inhibitory BH3 mimetic ABT-737 depletes platelet calcium stores. Blood 2012, 119(18), 4337-4338.
27. Baev, D. V.; Krawczyk, J.; M, O. D.; Szegezdi, E. The BH3-mimetic ABT-737 effectively kills acute myeloid leukemia initiating cells. Leuk. Res. Rep., 2014, 3(2),79-82.
28. Souers, A. J.; Leverson, J. D.; Boghaert, E. R.; Ackler, S. L.; Catron, N. D.; Chen, J.; Dayton, B. D.; Ding, H.; Enschede, S. H.; Fairbrother, W. J.; Huang, D. C.; Hymowitz, S. G.; Jin, S.; Khaw, S. L.; Kovar, P. J.; Lam, L. T.; Lee, J.; Maecker, H. L.; Marsh, K. C.; Mason, K. D.; Mitten, M. J.; Nimmer, P. M.; Oleksijew, A.; Park, C. H.; Park, C. M.; Phillips, D. C.; Roberts, A. W.; Sampath, D.; Seymour, J. F.; Smith, M. L.; Sullivan, G. M.; Tahir, S. K.; Tse, C.; Wendt, M. D.; Xiao, Y.; Xue, J. C.; Zhang, H.; Humerickhouse, R. A.; Rosenberg, S. H.; Elmore, S. W. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med., 2013, 19(2), 202-208.
29. Quinn, B. A.; Dash, R.; Azab, B.; Sarkar, S.; Das, S. K.; Kumar, S.; Oyesanya, R. A.; Dasgupta, S.; Dent, P.; Grant, S.; Rahmani, M.; Curiel, D. T.; Dmitriev, I.; Hedvat, M.; Wei, J.; Wu, B.; Stebbins, J. L.; Reed, J. C.; Pellecchia, M.; Sarkar, D.; Fisher, P. B. Targeting Mcl-1 for the therapy of cancer. Expert Opin. Investig. Drugs, 2011, 20(10), 1397-1411.
30. Classon, B. J.; Williams, A. F.; Willis, A. C.; Seed, B.; Stamenkovic, I. The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J. Exp. Med., 1990, 172(3), 1007.
31. Zhang, X.; Blaskovich, M. A.; Forinash, K. D.; Sebti, S. M. Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours. Br. J. Cancer, 2014, 111(5), 894-902.
32. Nam, S.; Buettner, R.; Turkson, J.; Kim, D.; Cheng, J. Q.; Muehlbeyer, S.; Hippe, F.; Vatter, S.; Merz, K. H.; Eisenbrand, G.; Jove, R. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc. Natl. Acad. Sci. U S A, 2005, 102(17), 5998-6003.
33. Muto, A.; Hori, M.; Sasaki, Y.; Saitoh, A.; Yasuda, I.; Maekawa, T.; Uchida, T.; Asakura, K.; Nakazato, T.; Kaneda, T.; Kizaki, M.; Ikeda, Y.; Yoshida, T. Emodin has a cytotoxic activity against human multiple myeloma as a Janus-Activated kinase 2 inhibitor. Mol. Cancer Ther., 2007, 6(3), 987-994.
34. Ban, D.; Funk, M.; Gulich, R.; Egger, D.; Sabo, T. M.; Walter, K. F.; Fenwick, R. B.; Giller, K.; Pichierri, F.; de Groot, B. L.; Lange, O. F.; Grubmuller, H.; Salvatella, X.; Wolf, M.; Loidl, A.; Kree, R.; Becker, S.; Lakomek, N. A.; Lee, D.; Lunkenheimer, P.; Griesinger, C. Kinetics of conformational sampling in ubiquitin. Angew. Chem. Int. Ed. Engl., 2011, 50(48), 11437-11440.
35. Kim, J.; Lee, Y. J.; Shin, D. S.; Jeon, S. H.; Son, K. H.; Han, D. C.; Jung, S. N.; Oh, T. K.; Kwon, B. M. Cosmomycin C inhibits signal transducer and activator of transcription 3 (STAT3), pathways in MDA-MB-468 breast cancer cell. Bioorg. Med. Chem., 2011, 19(24), 7582-7589.
36. Li, F.; Rajendran, P.; Sethi, G. Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway. Br. J. Pharmacol., 2010, 161(3), 541-54.
37. Polier, G.; Giaisi, M.; Kohler, R.; Muller, W. W.; Lutz, C.; Buss, E. C.; Krammer, P. H.; Li-Weber, M. Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263. Int. J. Cancer, 2014.
38. Page, B. D.; Khoury, H.; Laister, R. C.; Fletcher, S.; Vellozo, M.; Manzoli, A.; Yue, P.; Turkson, J.; Minden, M. D.; Gunning, P. T. Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity. J. Med. Chem., 2012, 55(3), 1047-55.
39. Zhang, S.; Li, G.; Ma, X.; Wang, Y.; Liu, G.; Feng, L.; Zhao, Y.; Zhang, G.; Wu, Y.; Ye, X.; Qin, B.; Lu, J. Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1. Cell Signal, 2012, 24(9), 1803-9.
40. Subramaniam, D.; Natarajan, G.; Ramalingam, S.; Ramachandran, I.; May, R.; Queimado, L.; Houchen, C. W.; Anant, S. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2. Am. J. Physiol. Gastrointest. Liver Physiol., 2008, 294(4), G1025-1032.
41. Mojsa, B.; Lassot, I.; Desagher, S. Mcl-1 ubiquitination: unique regulation of an essential survival protein. Cells, 2014, 3(2), 418-437.
42. Peddaboina, C.; Jupiter, D.; Fletcher, S.; Yap, J. L.; Rai, A.; Tobin, R. P.; Jiang, W.; Rascoe, P.; Rogers, M. K.; Smythe, W. R.; Cao, X. The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition. BMC Cancer, 2012, 12, 541.
43. Zhai, D.; Jin, C.; Shiau, C. W.; Kitada, S.; Satterthwait, A. C.; Reed, J. C. Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins. Mol. Cancer Ther., 2008, 7(6), 1639-1646.
44. Meng, Y.; Tang, W.; Dai, Y.; Wu, X.; Liu, M.; Ji, Q.; Ji, M.; Pienta, K.; Lawrence, T.; Xu, L. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Mol. Cancer Ther., 2008, 7(7), 2192-2202.
45. Etxebarria, A.; Landeta, O.; Antonsson, B.; Basanez, G. Regulation of antiapoptotic MCL-1 function by gossypol: mechanistic insights from in vitro reconstituted systems. Biochem. Pharmacol., 2008, 76(11), 1563-1576.
46. Doi, K.; Li, R.; Sung, S. S.; Wu, H.; Liu, Y.; Manieri, W.; Krishnegowda, G.; Awwad, A.; Dewey, A.; Liu, X.; Amin, S.; Cheng, C.; Qin, Y.; Schonbrunn, E.; Daughdrill, G.; Loughran, T. P. Jr.; Sebti, S.; Wang, H. G. Discovery of marinopyrrole A (maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasomal degradation. J. Biol. Chem., 2012, 287(13), 10224-10235.
47. Abeloos, L.; Maris, C.; Salmon, I.; Baleriaux, D.; Sadeghi, N.; Lefranc, F. Chondroma of the dural convexity: a case report and literature review. Neuropathology, 2012, 32(3), 306-310.
48. Zhu, H.; Yang, W.; He, L. J.; Ding, W. J.; Zheng, L.; Liao, S. D.; Huang, P.; Lu, W.; He, Q. J.; Yang, B. Upregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cells. PLoS One, 2012, 7(12), e52333.
49. Gao, N.; Cheng, S.; Budhraja, A.; Gao, Z.; Chen, J.; Liu, E. H.; Huang, C.; Chen, D.; Yang, Z.; Liu, Q.; Li, P.; Shi, X.; Zhang, Z. Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway. Br. J. Pharmacol., 2012, 165(6), 1813-1826.
50. Choi, E. S.; Jung, J. Y.; Lee, J. S.; Park, J. H.; Cho, N. P.; Cho, S. D. Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgenindependent prostate cancer cells and a tumor xenograft animal model. Cancer Lett., 2013, 328(1), 65-72.
51. Juncker, T.; Schumacher, M.; Dicato, M.; Diederich, M. UNBS1450 from Calotropis procera as a regulator of signaling pathways involved in proliferation and cell death. Biochem. Pharmacol., 2009, 78(1), 1-10.
52. Schumacher, M.; Cerella, C.; Eifes, S.; Chateauvieux, S.; Morceau, F.; Jaspars, M.; Dicato, M.; Diederich, M. Heteronemin, a spongean sesterterpene, inhibits TNF alphainduced NF-kappa B activation through proteasome inhibition and induces apoptotic cell death. Biochem. Pharmacol., 2010, 79(4), 610-622.
53. Munin, A.; Edwards-Levy, F. Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics, 2011, 3(4), 793-829.